Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University Hospital Birmingham British Heart Foundation |
---|---|
Information provided by: | University Hospital Birmingham |
ClinicalTrials.gov Identifier: | NCT00899483 |
The investigators have previously demonstrated that the administration of insulin in the form of an infusion with additional sugar and potassium may improve cardiovascular performance and reduce biochemical evidence of heart muscle injury in non-diabetic patients undergoing coronary artery surgery. The investigators now seek to demonstrate that similar benefits can be achieved in diabetic patients by administering insulin to maintain as near absolutely normal sugar levels as possible.
Condition | Intervention |
---|---|
Type 2 Diabetes |
Drug: Glucose potassium insulin solution |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Parallel Assignment |
Official Title: | Can Enhanced Glycaemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting? |
Estimated Enrollment: | 100 |
Study Start Date: | July 2009 |
Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Administered with glucose potassium insulin solution to achieve euglycaemia 4.0-6.0 mmol/L
|
Drug: Glucose potassium insulin solution
Enhanced glycaemic control in diabetics with glucose-potassium-insulin solution
|
2: No Intervention
Normal departmental practice using dextrose insulin infusion
|
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Robert S Bonser | 0121 4721311 ext 2559 | mailto:Robert.Bonser@uhb.nhs.uk |
Contact: Ashvini Menon | 07973674826 | ashvini.menon@gmail.com |
United Kingdom, West Midlands | |
University Hospital Birmingham | |
Birmingham, West Midlands, United Kingdom, B15 2TH |
Responsible Party: | University Hospital Birmingham ( Professor Robert S Bonser ) |
Study ID Numbers: | RRK3545 |
Study First Received: | May 11, 2009 |
Last Updated: | May 11, 2009 |
ClinicalTrials.gov Identifier: | NCT00899483 History of Changes |
Health Authority: | United Kingdom: Research Ethics Committee |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder Insulin |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders |